Can modulators of apolipoproteinB biogenesis serve as an alternate target for cholesterol-lowering drugs?

Title
Can modulators of apolipoproteinB biogenesis serve as an alternate target for cholesterol-lowering drugs?
Authors
Keywords
Cardiovascular disease, Cholesterol, ApolipoproteinB, Very Low Density Lipoprotein (VLDL), Endoplasmic Reticulum Associated Degradation (ERAD), Autophagy
Publisher
Elsevier BV
Online
2018-04-06
DOI
10.1016/j.bbalip.2018.03.010

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now